2.4 Trillion Reasons to Trade Biotech RIGHT NOW

*Editor’s Note: Our Catalyst Calendar event is available to view right now. Watch the recording of the event here.

One of the most important trading lessons you’ll ever learn is timing.

I’ve told you this countless times over the last 15 years, and that fact rings just as true today as it ever has.

Think back on any successful trade you’ve ever made, every gain you’ve ever pocketed. At some point, you looked at the market and told yourself you were ready to take your winnings off the table.

After all, one of the few axioms in investing is that a gain is never truly a gain until the cash hits your bank account.

Until then, you’re just holding paper.

Deep down, that’s the bitter pill of truth that every one of us has to swallow at some point.

Mind you, I’m not being specific to one particular sector or industry. This investing truth applies everywhere — just look at your own portfolio for proof. At one time or another, every single one of us has regretted selling a little too early or perhaps buying a little too late.

And make no mistake, you’ll always get a little FOMO at one point or another.

But do you want to know a truly dirty secret to a successful trade?

Timing isn’t everything.

More importantly, do you know the difference between a good trade and a great one?

Well, let me show you.

The Anatomy of Every Winning Trade You’ll Ever Make

I don’t care if you’re a novice trader doing it for fun or if your name is Warren Buffett and you’ve built a $109 billion empire on investing — learning to accurately time your trades is a critical tool that needs to be mastered.

But it’s not all.

I’m talking about a strategy.

You need a system in place that acts as a road map for your winning trades. Having a system in place is one way individual investors like us can stack the deck in our favor.

There’s nothing I love more than when a plan comes together and pays off in spades for my readers and me.

You see, my team and I scoured the markets years ago, biding our time and waiting for an opportunity that was too good to pass up. We spent years developing a system that couldn’t fail us, no matter which direction the broader market was trending.

I’m telling you today that we’ve not only found that market but also given our system a trial by fire.

And our unique trading system did more than pass our test with flying colors — it lined our pockets with cold, hard cash.

Now it’s time you joined us.

2.4 Trillion Reasons to Trade Biotech RIGHT NOW

No other industry has become so decisive in our daily lives as biotechnology.

Last year taught us that, didn’t it?

By now, you’ve probably heard about the fortune that investors raked in from trading companies like Moderna and Pfizer.

These two companies have become household names for obvious reasons. There’s even a good chance you carry the fruits of their research in your veins right now.

The good news is that these opportunities spring up every week in the biotech industry.

By 2028, the value of the biotech market is projected to hit $2.4 trillion and expected to grow at a CAGR of 15.8% over the next seven years.

That kind of growth potential is far too lucrative to ignore.

And here’s the best part: Successfully trading this biotech boom can be as easy as reading a calendar.

Don’t believe me?

My readers and I have already proved this biotech strategy works — time and time again.

But I don’t want you to simply take my word for it.

I want to SHOW you exactly how we did it.

Tomorrow I’m hosting a pivotal investment training event that will give you the exact details on how my readers and I are able to successfully uncover up to 144 trades each year.

Here’s a spoiler: You’ll learn more than simply how to pinpoint when a biotech stock is about explode higher; you’ll also learn where you’ll find these rich trading targets.

However, all I can do is open this door. The next step is up to you. 

I strongly urge you to take just a few moments out of your day tomorrow and learn all the details for yourself firsthand.

I’ll break it all down for you tomorrow at 3 p.m.

All you have to do is click here and secure your seat at the table.

Until next time,

Keith Kohl

Check us out on YouTube!

A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.

For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.

Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.